Why the study?
Do calcium channel blockers reduce cardiovascular events in patients with coronary artery disease?
Population
Patients with coronary artery disease
Comparison
Calcium channel blockers vs Placebo or enalapril
Design
Review
Authors
Loading...
Supports amlodipine in CAD to lower events; leaves open prospective RCT confirmation before practice change.
Do calcium channel blockers reduce cardiovascular events in patients with coronary artery disease?
Long-acting calcium channel blockers are safe and beneficial for reducing cardiovascular events, particularly revascularization and angina hospitalization, in patients with coronary artery disease.
Sheila A Doggrell (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: